NUSAP1 and oral cavity squamous cell carcinoma: Okamoto [35] demonstrated that inhibition of NUSAP1 suppressed tumor proliferation and enhanced the anti-tumor effect of paclitaxel by activating apoptotic pathways in oral squamous cell carcinoma.